ANI Pharmaceuticals Inc (NASDAQ:ANIP)
| 37.36 Delayed Data As of Mar 24 |  -0.46 / -1.22%Today’s Change | 22.31 Today|||52-Week Range 45.99 | -7.13% Year-to-Date |
Latest ANIP News | Press Releases
No recent news for ANI Pharmaceuticals Inc.
Today’s Trading
| Previous close | 37.82 |
| Today’s open | 36.91 |
| Day’s range | 36.60 - 37.84 |
| Volume | 6,622 |
| Average volume (3 months) | 71,307 |
| Market cap | $658.3M |
Data as of 3:59pm ET, 03/24/2023
Growth & Valuation
| Earnings growth (last year) | +10.36% |
| Earnings growth (this year) | +79.26% |
| Earnings growth (next 5 years) | +17.70% |
| Revenue growth (last year) | +46.38% |
| P/E ratio | NM |
| Price/Sales | 2.07 |
| Price/Book | 2.10 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| BCYCBicycle Therapeutics... | +0.20 | +0.98% |
| ---- | ||
| COGTCogent Biosciences I... | +0.07 | +0.70% |
| IBRXImmunitybio Inc | +0.19 | +13.01% |
Data as of 4:00pm ET, 03/24/2023
Financials
| Next reporting date | May 9, 2023 |
| EPS forecast (this quarter) | $0.35 |
| Annual revenue (last year) | $316.4M |
| Annual profit (last year) | -$47.9M |
| Net profit margin | -15.14% |
Profile
Sector Health Technology |
Industry Biotechnology |
No executives to display |
Corporate headquarters Baudette, Minnesota |
Forecasts
